Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer

NCT00864266 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Carcinoma

Interventions

DRUG: Chemotherapy

Sponsor

European Lung Cancer Working Party